Evidence map›Paper›PMID 24506535›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2014

Uncoupling of Cav1.2 from Ca(2+)-induced Ca(2+) release and SK channel regulation in pancreatic β-cells.

Yuchen Wang, Rachel E Jarrard, Evan P S Pratt, Marcy L Guerra, Amy E Salyer, Allison M Lange, Ian M Soderling, Gregory H Hockerman

Abstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. ERG1A KScientific reports · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yuchen WangPurdue University Life Sciences Graduate Program (R.E.J., E.P.S.P., A.M.L.) and Department of Medicinal Chemistry and Molecular Pharmacology (Y.W., M.L.G., A.E.S., I.M.S., G.H.H.), Purdue University, West Lafayette, Indiana 47907-2091.
Rachel E Jarrard
Evan P S Pratt
Marcy L Guerra
Amy E Salyer
Allison M Lange
Ian M Soderling
Gregory H Hockerman
Purdue University West Lafayette · US

Funding

L-type Ca2+ Channel Modulation of Beta Cell FunctionR01DK064736 · NIDDK · PURDUE UNIVERSITY WEST LAFAYETTE · PI HOCKERMAN, GREGORY HOWARD · 2004 to 2012
$2.2M
NIDDK NIH HHS R01 DK064736
6 · The paper itself

Abstract

We investigated the role of Cav1.2 in pancreatic β-cell function by expressing a Cav1.2 II-III loop/green fluorescent protein fusion in INS-1 cells (Cav1.2/II-III cells) to disrupt channel-protein interactions. Neither block of KATP channels nor stimulation of membrane depolarization by tolbutamide was different in INS-1 cells compared with Cav1.2/II-III cells, but whole-cell Cav current density was significantly increased in Cav1.2/II-III cells. Tolbutamide (200 μM) stimulated insulin secretion and Ca(2+) transients in INS-1 cells, and Cav1.2/II-III cells were completely blocked by nicardipine (2 μM), but thapsigargin (1 μM) blocked tolbutamide-stimulated secretion and Ca(2+) transients only in INS-1 cells. Tolbutamide-stimulated endoplasmic reticulum [Ca(2+)] decrease was reduced in Cav1.2/II-III cells compared with INS-1 cells. However, Ca(2+) transients in both INS-1 cells and Cav1.2/II-III cells were significantly potentiated by 8-pCPT-2'-O-Me-cAMP (5 μM), FPL-64176 (0.5 μM), or replacement of extracellular Ca(2+) with Sr(2+). Glucose (10 mM) + glucagon-like peptide-1 (10 nM) stimulated discrete spikes in [Ca(2+)]i in the presence of verapamil at a higher frequency in INS-1 cells than in Cav1.2/II-II cells. Glucose (18 mM) stimulated more frequent action potentials in Cav1.2/II-III cells and primary rat β-cells expressing the Cav1.2/II-II loop than in control cells. Further, apamin (1 μM) increased glucose-stimulated action potential frequency in INS-1 cells, but not Cav1.2/II-III cells, suggesting that SK channels were not activated under these conditions in Cav1.2/II-III loop-expressing cells. We propose the II-III loop of Cav1.2 as a key molecular determinant that couples the channel to Ca(2+)-induced Ca(2+) release and activation of SK channels in pancreatic β-cells.

Indexed as

Action PotentialsAnimalsCalciumCalcium Channels, L-TypeCell FractionationCentrifugation, Density GradientCyclic AMPEndocytosisEndoplasmic ReticulumEukaryotic Initiation Factor-3Glucagon-Like Peptide 1GlucoseImmunoprecipitationInsulinInsulin-Secreting CellsInsulin Secretion8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphateCalciumCalcium Channels, L-TypeCyclic AMPEukaryotic Initiation Factor-3Glucagon-Like Peptide 1GlucoseInsulinIQ motif containing GTPase activating protein 1L-type calcium channel alpha(1C)ras GTPase-Activating ProteinsSmall-Conductance Calcium-Activated Potassium ChannelsTolbutamideVerapamil

Identifiers

PMID24506535
PMCPMC3968403
OpenAlexW2027622791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.